MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore the role of genetic testing in early detection, treatment, and management of Methylmalonic Acidemia with Homocystinuria, Type cblJ, a rare metabolic disorder.
Explore how genetic testing unveils the mysteries of microcephalic primordial dwarfism, with insights into diagnosis, management, and family genetic counseling.
Uncover the role of genetic testing in diagnosing and managing Microcephaly 9. Learn about the MCM7 gene, early diagnosis, and family planning insights.
Understanding Mitochondrial Pyruvate Carrier Deficiency through genetic testing paves the way for accurate diagnosis, personalized treatments, and informed family planning.
Explore how genetic testing uncovers the NCOA5 gene's role in increased MS risk, aiding early detection, personalized interventions, and tailored treatment plans.
Discover how whole exome sequencing aids in diagnosing muscular dystrophy-dystroglycanopathy, facilitating early intervention and informed family planning.
Explore how genetic testing revolutionizes the diagnosis and treatment of muscular dystrophy-dystroglycanopathy, offering hope with personalized care strategies.
Explore muscular dystrophy-dystroglycanopathy type A13, a rare genetic disorder, and learn how genetic testing aids in accurate diagnosis and treatment strategies.